MGZ · Class II · 21 CFR 870.4885

FDA Product Code MGZ: Valvulotome

Leading manufacturers include Aveera Medical, Inc. and LimFlow, Inc..

27
Total
27
Cleared
191d
Avg days
1991
Since
Growing category - 2 submissions in the last 2 years vs 1 in the prior period
Review times improving: avg 112d recently vs 197d historically

FDA 510(k) Cleared Valvulotome Devices (Product Code MGZ)

27 devices
1–24 of 27

About Product Code MGZ - Regulatory Context

510(k) Submission Activity

27 total 510(k) submissions under product code MGZ since 1991, with 27 receiving FDA clearance (average review time: 191 days).

Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under MGZ have taken an average of 112 days to reach a decision - down from 197 days historically, suggesting improved FDA processing for this classification.

MGZ devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →